Abstract:Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment option for various types of cancers. Although it has shown remarkable effectiveness, this therapy is also associated with significant toxicity, which can limit its use. The most common adverse events associated with CAR T-cell infusion include cytokine release syndrome (CRS) and immune effector cellassociated neurotoxicity syndrome (ICANS). This review focuses on the less common toxicities of CAR T-cell products, including thos… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.